1,310 reports of this reaction
2.6% of all CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE reports
#7 most reported adverse reaction
FATIGUE is the #7 most commonly reported adverse reaction for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, manufactured by Sandoz Inc. There are 1,310 FDA adverse event reports linking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE to FATIGUE. This represents approximately 2.6% of all 49,809 adverse event reports for this drug.
Patients taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,310 FDA reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.6% of all adverse event reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, making it a notable side effect.
If you experience fatigue while taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.